目錄号 | MZ0701-5MG | 售價 | 318.00元 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
規格 | 5mg | 運輸溫度 | 室溫運輸 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
其他名稱 | Flagecidin; Wuningmeisu C; NSC76712; AI350846; 回香黴素; | 保存溫度 | 2-8ºC幹燥保存,或置于-20ºC長(cháng)期幹燥保存! | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CAS号 | 22862-76-6 | 有效期 | 2年(nián) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
應用 | 抗生(shēng)素;JNK激活劑 | 訂購數量 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
産品簡介: Anisomycin 茴香黴素
搜索關鍵詞: Anisomycin茴香黴素;Flagecidin;Protein synthesis inhibitor蛋白(bái)合成抑制劑;JNK activator JNK激活劑;SP600125;CAS NO:22862-76-6;
産品訂購:更大包裝或産品技(jì)術(shù)問題,請來電(diàn)/在線咨詢,電(diàn)話:021-54736159 。
産品描述: 茴香黴素(Anisomycin),來源于灰色鏈黴菌(Streptomyces griseolus)的吡咯烷抗生(shēng)素,是一(yī)種有效的蛋白(bái)合成抑制劑,通(tōng)過抑制真核生(shēng)物(wù)核糖體的肽酰轉移酶活性來發揮作用。據報(bào)道能(néng)誘導許多(duō)細胞的凋亡發生(shēng),包括早幼粒細胞白(bái)血病細胞、Jurkat細胞、心室肌細胞和結腸腺癌細胞。啓動胞内信号和立早基因誘導。 茴香黴素是強效的JNK激活劑,活化MAP激酶(JNK/SAPK和p38/RK)。作為(wèi)一(yī)種有效的信号通(tōng)路(lù)激動劑,選擇性引發即刻早期基因誘導的同源性脫敏(c-fos,fosB,c-jun,junB和junD)。茴香黴素(30mg/kg)表現出優于環孢黴素A(MZ2501-10MG)的免疫抑制活性,阻斷皮膚移植小(xiǎo)鼠的T細胞增殖。
産品特性
|
溶劑體積 濃度 |
1mg |
5 mg |
10mg |
1mM |
3.7693 mL |
18.8466 mL |
37.6932 mL |
5mM |
0.7539mL |
3.7693 mL |
7.5386 mL |
10mM |
0.3769 mL |
1.8847 mL |
3.7693 mL |
50mM |
0.0754 mL |
0.3769 mL |
0.7539mL |
文獻1,Yan J et al. c-Jun N-terminal kinase activation contributes to reduced connexin43 and development of atrial arrhythmias. Cardiovasc Res. 2013 Mar 1;97(3):589-97. PMID: 23241357 體外研究(細胞實驗): 細胞類型(Cell types):Mouse atrial myocyte line (HL-1) 實驗方法(Assay):Atrial myocytes were treated with 50 ng/mL anisomycin with or without 2 µmol/L SP600125, or a corresponding amount of the DMSO solvent for 16 or 24 h followed by biochemical or optical mapping studies. 體内研究(動物(wù)模型): 動物(wù)模型(Animal Model):Young (6 months) and aged (54 months) male New Zealand White rabbits 實驗方法(Assay):LA effective refractory period (AERP) was measured using an S1-S2 pacing protocol and atrial arrhythmias (AT/AF) were induced using burst pacing in open-chest heartsin young rabbits with (n = 4) or without (n = 5)anisomycin treatment (15 mg/kg, iv, four treatments over 9 days)and aged rabbits without anisomycin treatment (n = 6). |
文獻2,Lattal KM et al. Behavioral impairments caused by injections of the protein synthesis inhibitor anisomycin after contextual retrieval reverse with time. Proc Natl Acad Sci U S A. 2004 Mar 30; 101(13):4667-72. PMID: 15070775 體内研究(動物(wù)模型): 動物(wù)模型(Animal Model):Male C57BL/6 mice (8-12 weeks old) 配制方法(Formulation):Anisomycin wasdiluted in salineand dissolved in 1 M HCl. The pH was adjusted to≈7 with 1 M NaOH. 實驗方法(Assay):Mice received subcutaneous injections of 50 or 75 mg of anisomycin/kg of body weight or an equivalent volume of saline in the first experiment. Injections in all other experiments were 50 mg/kg of anisomycin or an equivalent volume of saline. |
文獻3,Guo Xet al. GSK3β regulates AKT-induced central nervous system axon regeneration via an eIF2Bε-dependent, mTORC1-independent pathway. Elife. 2016 Mar 14;5:e11903.PMID: 26974342. 體内研究(動物(wù)模型): 動物(wù)模型(Animal Model): 配制方法(Formulation):Anisomycin was dissolved inDMSO to prepare a stock solution anddiluted inPBS before each administration. 實驗方法(Assay):Anisomycin (30 mg/kg body weight)or vehicle was injected subcutaneously daily after optic nerve crush. To inhibit OPP incorporation, anisomycin (50 μg/ml) was injected intravitreally 1 hr before and together with OPP administration. |
相(xiàng)關産品:更大包裝或産品技(jì)術(shù)問題,請來電(diàn)/在線咨詢,電(diàn)話:021-54736159 。
貨号 |
産品名稱 |
規格 |
MZ0701-5MG |
Anisomycin 茴香黴素 |
5mg |
MZ0702-10MG |
SP600125 JNK抑制劑 |
10mg |
MZ0201-10MG |
Rapamycin (Sirolimus) 雷帕黴素(西(xī)羅莫司) |
10mg |
MZ2501-10MG |
Cyclosporin A (CsA) 環孢黴素A |
10mg |
注意事(shì)項
為(wèi)了您的安全和健康,請穿實驗服并戴一(yī)次性手套操作。
— —Written/Edited by V. Shallan【版權歸MKBio懋康所有】
上海夢澤生物科技有限公司是一(yī)家涉足于生(shēng)命科學和生(shēng)物(wù)技(jì)術(shù)領域研究的試劑、儀器(qì)和實驗室消耗品與實驗服務工(gōng)作,主要從(cóng)事(shì)細胞生(shēng)物(wù)學、植物(wù)學、分子生(shēng)物(wù)學、免疫學、生(shēng)物(wù)化學、蛋白(bái)組學。生(shēng)物(wù)制藥與診斷試劑研發生(shēng)産等領域。 本公司秉承“以人為(wèi)本,以誠為(wèi)信、合同守信”的經營理念。堅持"品質保障"的原則為(wèi)廣大客戶提供優質産品。